NDAORALFOR SUSPENSION
Approved
Jun 2001
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Mechanism of Action
ES-600 is an antibacterial drug [see Microbiology ()] .
Indications (10)
equal to 40 kg with: Recurrentpersistent acute otitis media due to Sacute otitis media due to Sdevelopment of drug-resistant bacteriamaintain the effectiveness of AUGMENTIN ES-600other antibacterial drugsAUGMENTIN ES-600 should be used only to treatprevent infectionsstrongly suspected to be caused by susceptible bacteriastrongly suspected to be caused by bacteria
Clinical Trials (1)
A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS
Started Oct 2023
0Infections, Bacterial